XML 22 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Total
ATM Offering
Underwritten Public Offering
Common Stock
Common Stock
ATM Offering
Common Stock
Underwritten Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
ATM Offering
Additional Paid-In Capital
Underwritten Public Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at Dec. 31, 2017 $ (3,059,537)     $ 13,929     $ 131,492,595       $ (134,566,061)
Balance, shares at Dec. 31, 2017       13,929,763              
Exercise of stock options 40,504     $ 18     40,486        
Exercise of stock options, shares       18,028              
Stock-based compensation expense 1,143,188           1,143,188        
Release of restricted stock awards 270     $ 270              
Release of restricted stock awards, shares       269,551              
Net share settlement of restricted stock award (133,513)     $ (35)     (133,478)        
Net share settlement of restricted stock award, shares       (34,769)              
Employee stock purchase plan expense $ 14,453           14,453        
Issuance of common stock   $ 556,706 $ 37,724,316   $ 262 $ 13,915   $ 556,444 $ 37,710,401    
Issuance of common stock, shares 5,733,314     261,352 261,352 13,915,000          
Issuance of common stock warrants in connection with MidCapTerm Loan $ 74,000           74,000        
Net loss (5,379,947)                   (5,379,947)
Unrealized gain (loss) on short-term investments (11,151)                 $ (11,151)  
Balance at Mar. 31, 2018 30,969,289     $ 28,359     170,898,089     (11,151) (139,946,008)
Balance, shares at Mar. 31, 2018       28,358,925              
Balance at Dec. 31, 2018 21,092,062     $ 28,585     172,086,909     (3,453) (151,019,979)
Balance, shares at Dec. 31, 2018       28,585,449              
Exercise of stock options 51,570     $ 22     51,548        
Exercise of stock options, shares       21,871              
Stock-based compensation expense 241,233           241,233        
Release of restricted stock awards 13     $ 13              
Release of restricted stock awards, shares       13,126              
Net share settlement of restricted stock award (9,685)     $ (4)     (9,681)        
Net share settlement of restricted stock award, shares       (3,813)              
Employee stock purchase plan expense 16,794           16,794        
Net loss (5,370,846)                   (5,370,846)
Unrealized gain (loss) on short-term investments 3,353                 3,353  
Foreign currency translation adjustment 6,439                 6,439  
Balance at Mar. 31, 2019 $ 16,030,933     $ 28,616     $ 172,386,803     $ 6,339 $ (156,390,825)
Balance, shares at Mar. 31, 2019       28,616,633